An AI Platform integrating imaging data and models, supporting precision care through prostate cancer’s continuum
The 5th ProCAncer-I Consortium Meeting took place on the 07 – 08 November 2022, at ILO Campus, in Turin. The meeting was hybrid and more than 65 people attended the meeting. This was the first physical meeting where almost all partners were present, and we were glad to get to know each other. During the project, the progress and various issues for the implementation of the project were discussed
The ProCAncer-I project aims to revolutionize prostate cancer diagnosis and treatment through the power of artificial intelligence and advanced imaging. By creating a large, federated database of prostate MRI scans and clinical data, the project enables the...
ProCAncer-I results | Prof. Daniele Regge on clinical validation In this video, we present the results of the clinical validation of AI models that were developed during the ProCAncer-i Project. Clinical validation is a critical step to ensure that AI tools not only...
ProCAncer-I results | Prof. Papanikolaou on Prostanet including PI-QUAL Study and tools Since its inception, the ProCAncer-I project has aimed to establish a robust, ethically compliant AI platform—ProstateNet—to revolutionize prostate cancer (PCa) care through...
In the following AI-generated audio file, ProCAncer-I achievements are described in a simple way. Since its inception, the ProCAncer-I project has been on a mission to transform prostate cancer (PCa) care through advanced AI and ethically compliant data platforms. At...